[Shiga toxin production by Escherichia coli strains and antibiotics].

S. Sidorenko

Abstract:

What problem does this paper attempt to address?

Potential for GPT Technology to Optimize Future Clinical Decision-Making Using Retrieval-Augmented Generation

Calvin Wang,Joshua Ong,Chara Wang,Hannah Ong,Rebekah Cheng,Dennis Ong

DOI: https://doi.org/10.1007/s10439-023-03327-6

Abstract:Advancements in artificial intelligence (AI) provide many helpful tools for healthcare, one of which includes AI chatbots that use natural language processing to create humanlike, conversational dialog. These chatbots have general cognitive skills and are able to engage with clinicians and patients to discuss patients' health conditions and what they may be at risk for. While chatbot engines have access to a wide range of medical texts and research papers, they currently provide high-level, generic responses and are limited in their ability to provide diagnostic guidance and clinical advice to patients on an individual level. The essay discusses the use of retrieval-augmented generation (RAG), which can be used to improve the specificity of user-entered prompts and thereby enhance the detail in AI chatbot responses. By embedding more recent clinical data and trusted medical sources, such as clinical guidelines, into the chatbot models, AI chatbots can provide more patient-specific guidance, faster diagnoses and treatment recommendations, and greater improvement of patient outcomes.
Generative AI and Patient Care: A Systematic Review Examining Applications, Limitations, and Future Directions for ChatGPT in Healthcare

Dominic Etli

DOI: https://doi.org/10.23880/jqhe-16000361

2024-01-01

Journal of Quality in Health Care & Economics

Abstract:Background: Generative artificial intelligence (AI) tools like ChatGPT have emerged as potentially valuable technologies to augment human expertise in healthcare. However, uncertainties remain regarding appropriate clinical applications and limitations. This review synthesizes current evidence on using generative AI for clinical decision support, patient data processing, and medical education. Methods: A systematic search of Web of Science, Scopus, and ProQuest databases identified 33 relevant studies published in 2023 examining ChatGPT for healthcare uses. Two reviewers extracted data on study characteristics, AI system details, key results, and authors' conclusions. Evidence was synthesized qualitatively using a comparative analysis approach. Results: Supervised use of ChatGPT-generated simulations appeared beneficial for clinical training, but oversight was critical. Numerous studies found risks in relying on ChatGPT's clinical suggestions given frequent factual errors, outdated recommendations, and inappropriate advice. However, ChatGPT demonstrated potential for enhancing workflows via medical documentation automation. Conclusions: While showing promise for constrained uses like supervised education and documentation, findings caution against open-ended ChatGPT integration in clinical practice currently. Additional large-scale comparative effectiveness research is imperative to establish evidence-based implementation guidance. Responsible translation requires governance, validation against literature, and focus on human-AI collaboration versus replacement. Further inquiry can illuminate best practices for balancing innovation and safety.
Using ChatGPT to predict the future of personalized medicine

George P Patrinos,Negar Sarhangi,Behnaz Sarrami,Nazli Khodayari,Bagher Larijani,Mandana Hasanzad

DOI: https://doi.org/10.1038/s41397-023-00316-9

Abstract:Personalized medicine is a novel frontier in health care that is based on each person's unique genetic makeup. It represents an exciting opportunity to improve the future of individualized health care for all individuals. Pharmacogenomics, as the main part of personalized medicine, aims to optimize and create a more targeted treatment approach based on genetic variations in drug response. It is predicted that future treatments will be algorithm-based instead of evidence-based that will consider a patient's genetic, transcriptomic, proteomic, epigenetic, and lifestyle factors resulting in individualized medication. A generative pretrained transformer (GPT) is an artificial intelligence (AI) tool that generates language resembling human-like writing enabling users to engage in a manner that is practically identical to speaking with a human being. GPT's predictive algorithms can respond to questions that have never been addressed. Chat Generative Pretrained Transformer (ChatGPT) is an AI chatbot's advanced with conversational capabilities. In the present study, questions were asked from ChatGPT about the future of personalized medicine and pharmacogenomics. ChatGPT predicted both to be a promising approach with a bright future that holds great promises in improving patient outcomes and transforming the field of medicine. But it still has several limitations that need to be solved.
Bacterial endotoxins: Comparison of mitogenic, polyclonal, antibody-inducing and toxicity activities

J. Šourek,M. Svobodová,R. Dvořák,J. Müller,K. Šůla,K. Nouza

DOI: https://doi.org/10.1007/BF02814502

Abstract:
OncoGPT: Enhancing oncological decision-making with ASCO guideline–trained AI.

Ramy El-Assal,Aziz Nazha

DOI: https://doi.org/10.1200/jco.2024.42.16_suppl.e13607

IF: 45.3

2024-05-31

Journal of Clinical Oncology

Abstract:e13607 Background: General-purpose language models like ChatGPT, while proficient in a wide array of topics, often lack the specialized knowledge and precision required for specific fields such as oncology. The American Society of Clinical Oncology (ASCO) guidelines offer a comprehensive resource for oncology professionals, yet sifting through extensive documents for specific information can be daunting. To bridge this gap, we introduce OncoGPT, a specialized GPT model, tailored to provide precise and guideline-adherent oncological advice. Methods: We leveraged GPT-4's advanced language understanding capabilities as the foundation for OncoGPT. This customization involved an extensive training regimen using the complete text of the ASCO clinical guidelines. The training process was meticulously designed to ensure that OncoGPT not only assimilates the detailed information within these guidelines but also understands the context and intricacies of oncological care. Additionally, we created disease-specific versions of OncoGPT, each fine-tuned with guideline subsets pertinent to particular oncological conditions. Further, the training was augmented with specific prompts to foster kind, sincere, and respectful interactions, especially for patient-oriented responses. The model was designed to discern whether the user is a healthcare professional or a patient and adjust the complexity of its responses accordingly. For patients, additional emphasis was placed on delivering information in a kind, responsible, and empathetic manner. Results: OncoGPT's performance was rigorously evaluated for accuracy and reasoning against real-world clinical scenarios. The responses generated by the model were meticulously reviewed by an experienced oncologist to confirm adherence to ASCO guidelines and clinical relevance. This assessment revealed a high level of precision and contextual understanding in OncoGPT's outputs, demonstrating its potential as a valuable tool for oncology practitioners. Importantly, it showed a remarkable ability to tailor its communication style based on the user's background, providing simplified explanations for patients and more detailed responses for professionals. An example of a specific OncoGPT: Breast Cancer OncoGPT: https://chat.openai.com/g/g-VcuECT3jg-oncogpt-breast-cancer Conclusions: OncoGPT represents a significant advancement in the application of AI for medical decision-making. By integrating the depth of ASCO guidelines into a responsive and accurate AI model, OncoGPT offers oncology professionals a powerful tool for accessible, guideline-compliant advice. This development marks a crucial step towards integrating AI more profoundly into specialized medical fields, enhancing both the efficiency and accuracy of clinical decision-making.

oncology
Innovations in Medicine: Exploring ChatGPT's Impact on Rare Disorder Management

Stefania Zampatti,Cristina Peconi,Domenica Megalizzi,Giulia Calvino,Giulia Trastulli,Raffaella Cascella,Claudia Strafella,Carlo Caltagirone,Emiliano Giardina

DOI: https://doi.org/10.3390/genes15040421

IF: 4.141

2024-03-29

Genes

Abstract:Artificial intelligence (AI) is rapidly transforming the field of medicine, announcing a new era of innovation and efficiency. Among AI programs designed for general use, ChatGPT holds a prominent position, using an innovative language model developed by OpenAI. Thanks to the use of deep learning techniques, ChatGPT stands out as an exceptionally viable tool, renowned for generating human-like responses to queries. Various medical specialties, including rheumatology, oncology, psychiatry, internal medicine, and ophthalmology, have been explored for ChatGPT integration, with pilot studies and trials revealing each field's potential benefits and challenges. However, the field of genetics and genetic counseling, as well as that of rare disorders, represents an area suitable for exploration, with its complex datasets and the need for personalized patient care. In this review, we synthesize the wide range of potential applications for ChatGPT in the medical field, highlighting its benefits and limitations. We pay special attention to rare and genetic disorders, aiming to shed light on the future roles of AI-driven chatbots in healthcare. Our goal is to pave the way for a healthcare system that is more knowledgeable, efficient, and centered around patient needs.

genetics & heredity
Evaluating generative AI responses to real-world drug-related questions

Salvatore Giorgi,Kelsey Isman,Tingting Liu,Zachary Fried,João Sedoc,Brenda Curtis

DOI: https://doi.org/10.1016/j.psychres.2024.116058

Abstract:Generative Artificial Intelligence (AI) systems such as OpenAI's ChatGPT, capable of an unprecedented ability to generate human-like text and converse in real time, hold potential for large-scale deployment in clinical settings such as substance use treatment. Treatment for substance use disorders (SUDs) is particularly high stakes, requiring evidence-based clinical treatment, mental health expertise, and peer support. Thus, promises of AI systems addressing deficient healthcare resources and structural bias are relevant within this domain, especially in an anonymous setting. This study explores the effectiveness of generative AI in answering real-world substance use and recovery questions. We collect questions from online recovery forums, use ChatGPT and Meta's LLaMA-2 for responses, and have SUD clinicians rate these AI responses. While clinicians rated the AI-generated responses as high quality, we discovered instances of dangerous disinformation, including disregard for suicidal ideation, incorrect emergency helplines, and endorsement of home detox. Moreover, the AI systems produced inconsistent advice depending on question phrasing. These findings indicate a risky mix of seemingly high-quality, accurate responses upon initial inspection that contain inaccurate and potentially deadly medical advice. Consequently, while generative AI shows promise, its real-world application in sensitive healthcare domains necessitates further safeguards and clinical validation.
PharmacyGPT: The AI Pharmacist

Zhengliang Liu,Zihao Wu,Mengxuan Hu,Bokai Zhao,Lin Zhao,Tianyi Zhang,Haixing Dai,Xianyan Chen,Ye Shen,Sheng Li,Quanzheng Li,Xiang Li,Brian Murray,Tianming Liu,Andrea Sikora

2024-10-04

Abstract:In this study, we introduce PharmacyGPT, a novel framework to assess the capabilities of large language models (LLMs) such as ChatGPT and GPT-4 in emulating the role of clinical pharmacists. Our methodology encompasses the utilization of LLMs to generate comprehensible patient clusters, formulate medication plans, and forecast patient outcomes. We conduct our investigation using real data acquired from the intensive care unit (ICU) at the University of North Carolina Chapel Hill (UNC) Hospital. Our analysis offers valuable insights into the potential applications and limitations of LLMs in the field of clinical pharmacy, with implications for both patient care and the development of future AI-driven healthcare solutions. By evaluating the performance of PharmacyGPT, we aim to contribute to the ongoing discourse surrounding the integration of artificial intelligence in healthcare settings, ultimately promoting the responsible and efficacious use of such technologies.

Computation and Language
Empowering Pharmacovigilance: Unleashing the Potential of Generative AI in Drug Safety Monitoring

John Praveen

DOI: https://doi.org/10.37022/jiaps.v8i2.464

2023-07-29

Journal of Innovations in Applied Pharmaceutical Science (JIAPS)

Abstract:Pharmacovigilance plays a crucial role in ensuring drug safety and promoting patient well-being throughout the life cycle of medicinal products. However, this field faces several challenges, including underreporting of adverse events, data quality issues, and the complexity of signal detection in large datasets. To address these challenges and enhance drug safety monitoring, there is a growing interest in harnessing the potential of generative artificial intelligence (AI) techniques. This article explores the applications and implications of generative AI in pharmacovigilance. It provides an overview of popular generative models and their working principles, highlighting their ability to analyse drug databases, medical literature, and real-world data sources to identify drug-drug interactions, adverse events, and potential safety signals. Moreover, it emphasizes the importance of human validation and expert oversight in interpreting and acting on the insights generated by generative AI algorithms. The integration of generative AI with traditional pharmacovigilance methods creates a synergistic approach, combining the computational power of AI with human expertise. This integration can lead to improved signal detection, efficient case report generation, proactive risk assessment, and optimized resource allocation. Additionally, the article addresses challenges related to data quality, interpretability, and model validation in generative AI applications, emphasizing the need for standardized protocols and collaborative efforts among stakeholders. Overall, the potential of generative AI in pharmacovigilance is vast. By leveraging its capabilities, we can enhance drug safety monitoring, facilitate early detection of adverse events, and improve patient outcomes. However, it is crucial to address ethical considerations, ensure data privacy, and maintain human oversight to foster responsible and effective implementation of generative AI in pharmacovigilance practices.
Generative artificial intelligence models in clinical infectious disease consultations: a cross-sectional analysis among specialists and resident trainees

Edwin Kwan-Yeung Chiu,Siddharth Sridhar,Samson Sai-Yin Wong,Anthony Raymond Tam,Ming-Hong Choi,Alicia Wing-Tung Lau,Wai-Ching Wong,Kelvin Hei-Yeung Chiu,Yuey-Zhun Ng,Kwok-Yung Yuen,Tom Wai-Hin Chung

DOI: https://doi.org/10.1101/2024.08.15.24312054

2024-08-19

Abstract:Background The potential of generative artificial intelligence (GenAI) to augment clinical consultation services in clinical microbiology and infectious diseases (ID) is being evaluated. Methods This cross-sectional study evaluated the performance of four GenAI chatbots (GPT-4.0, a Custom Chatbot based on GPT-4.0, Gemini Pro, and Claude 2) by analysing 40 unique clinical scenarios synthesised from real-life clinical notes. Six specialists and resident trainees from clinical microbiology or ID units conducted randomised, blinded evaluations across four key domains: factual consistency, comprehensiveness, coherence, and medical harmfulness. Results Analysis of 960 human evaluation entries by six clinicians, covering 160 AI-generated responses, showed that GPT-4.0 produced longer responses than Gemini Pro (p<0·001) and Claude 2 (p<0·001), averaging 577 ±81·19 words. GPT-4.0 achieved significantly higher mean composite scores compared to Gemini Pro [mean difference (MD)=0·2313, p=0·001] and Claude 2 (MD=0·2021, p=0·006). Specifically, GPT-4.0 outperformed Gemini Pro and Claude 2 in factual consistency (Gemini Pro, p=0·02 Claude 2, p=0·02), comprehensiveness (Gemini Pro, p=0·04; Claude 2, p=0·03), and the absence of medical harm (Gemini Pro, p=0·02; Claude 2, p=0·04). Within-group comparisons showed that specialists consistently awarded higher ratings than resident trainees across all assessed domains (p<0·001) and overall composite scores (p<0·001). Specialists were 9 times more likely to recognise responses with "Fully verified facts" and 5 times more likely to consider responses as "Harmless". However, post-hoc analysis revealed that specialists may inadvertently disregard conflicting or inaccurate information in their assessments, thereby erroneously assigning higher scores. Interpretation Clinical experience and domain expertise of individual clinicians significantly shaped the interpretation of AI-generated responses. In our analysis, we have demonstrated disconcerting human vulnerabilities in safeguarding against potentially harmful outputs. This fallibility seemed to be most apparent among experienced specialists and domain experts, revealing an unsettling paradox in the human evaluation and oversight of advanced AI systems. Stakeholders and developers must strive to control and mitigate user-specific and cognitive biases, thereby maximising the clinical impact and utility of AI technologies in healthcare delivery.

Infectious Diseases (except HIV/AIDS)
Exploring the landscape of AI-assisted decision-making in head and neck cancer treatment: a comparative analysis of NCCN guidelines and ChatGPT responses

Filippo Marchi,Elisa Bellini,Andrea Iandelli,Claudio Sampieri,Giorgio Peretti

DOI: https://doi.org/10.1007/s00405-024-08525-z

2024-02-29

European Archives of Oto-Rhino-Laryngology

Abstract:PurposeRecent breakthroughs in natural language processing and machine learning, exemplified by ChatGPT, have spurred a paradigm shift in healthcare. Released by OpenAI in November 2022, ChatGPT rapidly gained global attention. Trained on massive text datasets, this large language model holds immense potential to revolutionize healthcare. However, existing literature often overlooks the need for rigorous validation and real-world applicability.MethodsThis head-to-head comparative study assesses ChatGPT’s capabilities in providing therapeutic recommendations for head and neck cancers. Simulating every NCCN Guidelines scenarios. ChatGPT is queried on primary treatments, adjuvant treatment, and follow-up, with responses compared to the NCCN Guidelines. Performance metrics, including sensitivity, specificity, and F1 score, are employed for assessment.ResultsThe study includes 68 hypothetical cases and 204 clinical scenarios. ChatGPT exhibits promising capabilities in addressing NCCN-related queries, achieving high sensitivity and overall accuracy across primary treatment, adjuvant treatment, and follow-up. The study's metrics showcase robustness in providing relevant suggestions. However, a few inaccuracies are noted, especially in primary treatment scenarios.ConclusionOur study highlights the proficiency of ChatGPT in providing treatment suggestions. The model's alignment with the NCCN Guidelines sets the stage for a nuanced exploration of AI's evolving role in oncological decision support. However, challenges related to the interpretability of AI in clinical decision-making and the importance of clinicians understanding the underlying principles of AI models remain unexplored. As AI continues to advance, collaborative efforts between models and medical experts are deemed essential for unlocking new frontiers in personalized cancer care.

otorhinolaryngology
Evaluating Use of Generative Artificial Intelligence in Clinical Pathology Practice: Opportunities and the Way Forward

Peter McCaffrey,Ronald Jackups,Jansen Seheult,Mark A Zaydman,Ulysses Balis,Harshwardhan M Thaker,Hooman Rashidi,Rama R Gullapalli

DOI: https://doi.org/10.5858/arpa.2024-0208-RA

2024-10-10

Abstract:Context.—: Generative artificial intelligence (GAI) technologies are likely to dramatically impact health care workflows in clinical pathology (CP). Applications in CP include education, data mining, decision support, result summaries, and patient trend assessments. Objective.—: To review use cases of GAI in CP, with a particular focus on large language models. Specific examples are provided for the applications of GAI in the subspecialties of clinical chemistry, microbiology, hematopathology, and molecular diagnostics. Additionally, the review addresses potential pitfalls of GAI paradigms. Data sources.—: Current literature on GAI in health care was reviewed broadly. The use case scenarios for each CP subspecialty review common data sources generated in each subspecialty. The potential for utilization of CP data in the GAI context was subsequently assessed, focusing on issues such as future reporting paradigms, impact on quality metrics, and potential for translational research activities. Conclusions.—: GAI is a powerful tool with the potential to revolutionize health care for patients and practitioners alike. However, GAI must be implemented with much caution considering various shortcomings of the technology such as biases, hallucinations, practical challenges of implementing GAI in existing CP workflows, and end-user acceptance. Human-in-the-loop models of GAI implementation have the potential to revolutionize CP by delivering deeper, meaningful insights into patient outcomes both at an individual and population level.
Automating Responses to Patient Portal Messages Using Generative AI

Amarpreet Kaur,Alex Budko,Katrina Liu,Eric Eaton,Bryan Steitz,Kevin B. Johnson,Kaur,A.,Budko,A.,Liu,K.,Eaton,E.,Steitz,B.,Johnson,K. B.

DOI: https://doi.org/10.1101/2024.04.25.24306183

2024-04-26

MedRxiv

Abstract:Background: Patient portals serve as vital bridges between patients and providers, playing an increasing role in healthcare communication. The rising volume and complexity of these messages is exacerbating physician and nursing burnout. Recent studies have demonstrated that AI chatbots can generate message responses that are viewed favorably by healthcare professionals; however, these studies have not included the diverse range of messages typically found in patient portals. Our goal is to investigate the quality of GPT-generated message responses across the spectrum of message types within a patient portal. Methods: We used novel prompt engineering techniques to craft synthetic responses tailored to adult primary care patients. We enrolled a sample of primary care providers in a cross-sectional study to compare authentic with synthetic patient portal message responses, generated by GPT-4. The survey assessed each messages empathy, relevance, medical accuracy, and readability on a scale from 0 to 5. Respondents were asked to identify messages that were GPT-generated vs. provider-generated. Mean scores for all metrics were computed for subsequent analysis. Results: A total of 49 health care providers participated in the survey (59% completion rate), comprising 16 physicians and 32 advanced practice providers (APPs). When presented with GPT vs. authentic message response pairs, participants correctly identified GPT-generated responses 73% of the time and correctly identified authentic responses 50% of the time. In comparison to messages generated by physicians, GPT-4 generated messages exhibited higher mean scores for empathy (3.57 vs. 3.07, p < 0.001), relevance (3.94 vs. 3.81, p = 0.08) accuracy (4.05 vs. 3.95, p= 0.12) and readability (4.5 vs. 4.13, p < 0.001). Limitations: The study is a single-site, single-specialty study, limited due to the use of synthetic data. Conclusion: Our findings affirm the potential of GPT-generated patient portal message responses to achieve comparable levels of empathy, relevance, and readability to those found in typical responses according to the health care providers and indicates promising prospects for their integration in the healthcare sector. Additional studies should be done within provider workflows and with careful evaluation of patient attitudes and concerns related to the ethics as well as the quality of generated patient portal message responses in all settings.
Harnessing the Power of Generative Artificial Intelligence in Pathology Education

Matthew J Cecchini,Michael J Borowitz,Eric F Glassy,Rama R Gullapalli,Steven N Hart,Lewis A Hassell,Robert J Homer,Ronald Jackups Jr,Jeffrey L McNeal,Scott R Anderson

DOI: https://doi.org/10.5858/arpa.2024-0187-RA

2024-09-30

Abstract:Context.—: Generative artificial intelligence (AI) technologies are rapidly transforming numerous fields, including pathology, and hold significant potential to revolutionize educational approaches. Objective.—: To explore the application of generative AI, particularly large language models and multimodal tools, for enhancing pathology education. We describe their potential to create personalized learning experiences, streamline content development, expand access to educational resources, and support both learners and educators throughout the training and practice continuum. Data sources.—: We draw on insights from existing literature on AI in education and the collective expertise of the coauthors within this rapidly evolving field. Case studies highlight practical applications of large language models, demonstrating both the potential benefits and unique challenges associated with implementing these technologies in pathology education. Conclusions.—: Generative AI presents a powerful tool kit for enriching pathology education, offering opportunities for greater engagement, accessibility, and personalization. Careful consideration of ethical implications, potential risks, and appropriate mitigation strategies is essential for the responsible and effective integration of these technologies. Future success lies in fostering collaborative development between AI experts and medical educators, prioritizing ongoing human oversight and transparency to ensure that generative AI augments, rather than supplants, the vital role of educators in pathology training and practice.
ChatGPT in Diabetes Care: An Overview of the Evolution and Potential of Generative Artificial Intelligence Model Like ChatGPT in Augmenting Clinical and Patient Outcomes in the Management of Diabetes

Amit Kumar Dey

DOI: https://doi.org/10.4103/ijdt.ijdt_31_23

2023-01-01

Abstract:Abstract The rapid evolution of artificial intelligence (AI) technologies has brought a new era in health care, offering innovative solutions for various medical disciplines, including diabetes care. This viewpoint article aimed to elucidate the transformative potential of Chat Generative Pre-trained Transformer (ChatGPT), a large language model (LLM), in augmenting diabetes care. We traverse through the historical evolution of AI, delineating its trajectory from conceptual origins to contemporary advancements. Central to our discussion is the exploration of ChatGPT’s capabilities in fostering enhanced patient engagement, personalized medical guidance, and streamlined health-care workflows. Through a comprehensive review, we underscore ChatGPT as a pivotal technology, focused to revolutionize traditional paradigms in diabetes management and patient care.
Evaluation of oral administration of folic and folinic acid to prevent folate deficiency in patients with inflammatory bowel disease treated with salicylazosulfapyridine.

L. Pironi,G. Cornia,Ursitti Ma,M. A. Dallasta,R. Miniero,F. Fasano,M. Miglioli,Luigi Barbara

Abstract:In order to evaluate the efficacy of oral administration of a pharmacological dose of folic or of folinic acid to prevent the folate deficiency in patients with inflammatory bowel disease (IBD) treated with salicylazosulfapyridine (SASP) (1g twice daily at meal times), two groups of 15 patients with IBD received 15 mg/day of folic or folinic acid for one month. In both the groups there were ten patients affected by Crohn's disease and five patients affected by ulcerative colitis. Before starting the treatment, the plasma folate and the red blood cell (RBC) folate concentrations did not statistically differ between the two groups. After one month the mean increase in RBC folate concentration was significantly greater after folinic therapy then after folic acid therapy (910 +/- 383 versus 570 +/- 212 ng/ml; p less than 0.01), while no difference was observed in the mean increase of plasma folate level (19.8 +/- 6.6 versus 18.5 +/- 5.0 ng/ml). It was concluded that: a) both folic and folinic acid could restore and enlarge the body stores of folate in patients with IBD treated with SASP, when administered at the dose of 15 mg daily for one month; b) folinic acid seems to be more efficient in enlarging the body stores of the vitamin than folic acid.
Comparative Analysis of Drug-GPT and ChatGPT LLMs for Healthcare Insights: Evaluating Accuracy and Relevance in Patient and HCP Contexts

Giorgos Lysandrou,Roma English Owen,Kirsty Mursec,Grant Le Brun,Elizabeth A. L. Fairley

DOI: https://doi.org/10.48550/arXiv.2307.16850

2023-07-25

Abstract:This study presents a comparative analysis of three Generative Pre-trained Transformer (GPT) solutions in a question and answer (Q&A) setting: Drug-GPT 3, Drug-GPT 4, and ChatGPT, in the context of healthcare applications. The objective is to determine which model delivers the most accurate and relevant information in response to prompts related to patient experiences with atopic dermatitis (AD) and healthcare professional (HCP) discussions about diabetes. The results demonstrate that while all three models are capable of generating relevant and accurate responses, Drug-GPT 3 and Drug-GPT 4, which are supported by curated datasets of patient and HCP social media and message board posts, provide more targeted and in-depth insights. ChatGPT, a more general-purpose model, generates broader and more general responses, which may be valuable for readers seeking a high-level understanding of the topics but may lack the depth and personal insights found in the answers generated by the specialized Drug-GPT models. This comparative analysis highlights the importance of considering the language model's perspective, depth of knowledge, and currency when evaluating the usefulness of generated information in healthcare applications.

Computation and Language,Artificial Intelligence
Intervals to blood feeding following emergence and oviposition in Aedes triseriatus (Diptera: Culicidae).

C. Porter,G. Defoliart,B. Miller,P. Nemenyi

DOI: https://doi.org/10.1093/JMEDENT/23.2.222

1986-03-31

Journal of Medical Entomology

Abstract:Laboratory studies of Aedes triseriatus were conducted to determine the intervals from eclosion to initiation of blood feeding and from oviposition to renewed blood-feeding activity. A total of 196 females were given an opportunity to feed on suckling mice at 24-h intervals from emergence until either they took a blood meal or the experiment ended at day 39. The median time from emergence to blood feeding was 2.6 days (63 h). The median time from oviposition to a 2nd blood meal was estimated to be 1.6 days (38 h). When repeated with a younger group of females, the median time from oviposition to 2nd blood meal was estimated to be 19 h. The results indicate that newly emerged females of Ae. triseriatus are physiologically ready to blood feed several days before they are receptive to mating.
Assessing Generative Pretrained Transformers (GPT) in Clinical Decision-Making: Comparative Analysis of GPT-3.5 and GPT-4

Adi Lahat,Kassem Sharif,Narmin Zoabi,Yonatan Shneor Patt,Yousra Sharif,Lior Fisher,Uria Shani,Mohamad Arow,Roni Levin,Eyal Klang

DOI: https://doi.org/10.2196/54571

2024-06-27

Abstract:Background: Artificial intelligence, particularly chatbot systems, is becoming an instrumental tool in health care, aiding clinical decision-making and patient engagement. Objective: This study aims to analyze the performance of ChatGPT-3.5 and ChatGPT-4 in addressing complex clinical and ethical dilemmas, and to illustrate their potential role in health care decision-making while comparing seniors' and residents' ratings, and specific question types. Methods: A total of 4 specialized physicians formulated 176 real-world clinical questions. A total of 8 senior physicians and residents assessed responses from GPT-3.5 and GPT-4 on a 1-5 scale across 5 categories: accuracy, relevance, clarity, utility, and comprehensiveness. Evaluations were conducted within internal medicine, emergency medicine, and ethics. Comparisons were made globally, between seniors and residents, and across classifications. Results: Both GPT models received high mean scores (4.4, SD 0.8 for GPT-4 and 4.1, SD 1.0 for GPT-3.5). GPT-4 outperformed GPT-3.5 across all rating dimensions, with seniors consistently rating responses higher than residents for both models. Specifically, seniors rated GPT-4 as more beneficial and complete (mean 4.6 vs 4.0 and 4.6 vs 4.1, respectively; P<.001), and GPT-3.5 similarly (mean 4.1 vs 3.7 and 3.9 vs 3.5, respectively; P<.001). Ethical queries received the highest ratings for both models, with mean scores reflecting consistency across accuracy and completeness criteria. Distinctions among question types were significant, particularly for the GPT-4 mean scores in completeness across emergency, internal, and ethical questions (4.2, SD 1.0; 4.3, SD 0.8; and 4.5, SD 0.7, respectively; P<.001), and for GPT-3.5's accuracy, beneficial, and completeness dimensions. Conclusions: ChatGPT's potential to assist physicians with medical issues is promising, with prospects to enhance diagnostics, treatments, and ethics. While integration into clinical workflows may be valuable, it must complement, not replace, human expertise. Continued research is essential to ensure safe and effective implementation in clinical environments.
Use of American Society of Anesthesiologists physical status classification to assess perioperative risk in patients undergoing radical nephrectomy for renal cell carcinoma.

Ken‐ryu Han,Hyung L. Kim,A. Pantuck,F. Dorey,R. Figlin,A. Belldegrun

DOI: https://doi.org/10.1016/J.UROLOGY.2003.12.048

IF: 2.633

2004-05-01

Urology

Abstract:

[Shiga toxin production by Escherichia coli strains and antibiotics].

Potential for GPT Technology to Optimize Future Clinical Decision-Making Using Retrieval-Augmented Generation

Generative AI and Patient Care: A Systematic Review Examining Applications, Limitations, and Future Directions for ChatGPT in Healthcare

Using ChatGPT to predict the future of personalized medicine

Bacterial endotoxins: Comparison of mitogenic, polyclonal, antibody-inducing and toxicity activities

OncoGPT: Enhancing oncological decision-making with ASCO guideline–trained AI.

Innovations in Medicine: Exploring ChatGPT's Impact on Rare Disorder Management

Evaluating generative AI responses to real-world drug-related questions

PharmacyGPT: The AI Pharmacist

Empowering Pharmacovigilance: Unleashing the Potential of Generative AI in Drug Safety Monitoring

Generative artificial intelligence models in clinical infectious disease consultations: a cross-sectional analysis among specialists and resident trainees

Exploring the landscape of AI-assisted decision-making in head and neck cancer treatment: a comparative analysis of NCCN guidelines and ChatGPT responses

Evaluating Use of Generative Artificial Intelligence in Clinical Pathology Practice: Opportunities and the Way Forward

Automating Responses to Patient Portal Messages Using Generative AI

Harnessing the Power of Generative Artificial Intelligence in Pathology Education

ChatGPT in Diabetes Care: An Overview of the Evolution and Potential of Generative Artificial Intelligence Model Like ChatGPT in Augmenting Clinical and Patient Outcomes in the Management of Diabetes

Evaluation of oral administration of folic and folinic acid to prevent folate deficiency in patients with inflammatory bowel disease treated with salicylazosulfapyridine.

Comparative Analysis of Drug-GPT and ChatGPT LLMs for Healthcare Insights: Evaluating Accuracy and Relevance in Patient and HCP Contexts

Intervals to blood feeding following emergence and oviposition in Aedes triseriatus (Diptera: Culicidae).

Assessing Generative Pretrained Transformers (GPT) in Clinical Decision-Making: Comparative Analysis of GPT-3.5 and GPT-4

Use of American Society of Anesthesiologists physical status classification to assess perioperative risk in patients undergoing radical nephrectomy for renal cell carcinoma.